Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
- September -
Oktober
-
November
- December |
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
-
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
- 2025
December 2025 - 111 products
IP
CI
Bylvay®
30
k.A.
Ipsen Pharma Schweiz
GmbH
FB
G
IP
Denosumab-Teva onco,
Injektionslösung
k.A.
Teva Pharma AG
FB
G
IP
CI
LYVDELZI®, Hartkapsel
30
k.A.
Gilead Sciences
Switzerland Sàrl
FB
G
IP
CI
Yorvipath®
2 x 1
k.A.
Ascendis Pharma
Switzerland GmbH
FB
G
IP
CI
BEYONTTRA
120
k.A.
Comprimés filmés: Acoramidisum 356 mg
Bayer (Schweiz) AG
B
FB
G
Eltrombopag Devatis 12,5 mg
14
k.A.
Comprimés filmés: Eltrombopagum 12.5 mg
Devatis AG
FB
G
Pomalidomid Devatis 1 mg
14
k.A.
Capsules: Pomalidomidum 1 mg
Devatis AG
FB
G
Pomalidomid Devatis 1 mg
21
k.A.
Capsules: Pomalidomidum 1 mg
Devatis AG
FB
G
Pomalidomid Devatis 2 mg
14
k.A.
Capsules: Pomalidomidum 2 mg
Devatis AG
FB
G
Pomalidomid Devatis 2 mg
21
k.A.
Capsules: Pomalidomidum 2 mg
Devatis AG
FB
G
Pomalidomid Devatis 3 mg
14
k.A.
Capsules: Pomalidomidum 3 mg
Devatis AG
FB
G
Pomalidomid Devatis 3 mg
21
k.A.
Capsules: Pomalidomidum 3 mg
Devatis AG
FB
G
Pomalidomid Devatis 4 mg
14
k.A.
Capsules: Pomalidomidum 4 mg
Devatis AG
FB
G
Pomalidomid Devatis 4 mg
21
k.A.
Capsules: Pomalidomidum 4 mg
Devatis AG
FB
G
IP
Yorvipath 294 μg/0.98 ml
2 x 1
k.A.
Injektionslösung im Fertigpen: Palopegteriparatidum 3387 µg
Ascendis Pharma
Switzerland GmbH
B
FB
G
IP
Yorvipath 294 μg/0.98 ml
2
k.A.
Injektionslösung im Fertigpen: Palopegteriparatidum 3387 µg
Ascendis Pharma
Switzerland GmbH
B
FB
G
IP
Yorvipath 420 μg/1.4 ml
2 x 1
k.A.
Injektionslösung im Fertigpen: Palopegteriparatidum 4838 µg
Ascendis Pharma
Switzerland GmbH
B
FB
G
IP
Yorvipath 420 μg/1.4 ml
2
k.A.
Injektionslösung im Fertigpen: Palopegteriparatidum 4838 µg
Ascendis Pharma
Switzerland GmbH
B
FB
G
IP
CI
neotylol Grippe
12
k.A.
Pulver zur Herstellung einer Lösung zum Einnehmen: 4 Active Agents
NOBEL Pharma Schweiz AG
D
FB
G
CM
Gomintia,
Injektionslösung im
Fertigpen 50 mg/0.5 ml
k.A.
Golimumabum 50mg / 0.5ml
Janssen-Cilag AG
FB
G
CM
Gomintia,
Injektionslösung in einer
Fertigspritze 50 mg/0.5 ml
k.A.
Golimumabum 50mg / 0.5ml
Janssen-Cilag AG
FB
G
CM
Gomintia,
Injektionslösung in einer
Fertigspritze 100 mg/1 ml
k.A.
Golimumabum 100 mg/ml
Janssen-Cilag AG
FB
G
Qalsody
k.A.
Biogen Switzerland AG
FB
G
CM
Zoledronat osteo Aspen 5
mg/100 ml
100 ml
k.A.
Solution pour perfusion: Acidum Zoledronicum 5mg / 100ml
Ipsen Pharma Schweiz
GmbH
FB
G
Curapressin 1 mg/5 ml
5 x 5 ml
k.A.
Solution injectable: Terlipressini Acetas 1mg / 5ml
Curatis AG
FB
G
Curapressin 2 mg/10 ml
5 x 10 ml
k.A.
Solution injectable: Terlipressini Acetas 2mg / 10ml
Curatis AG
FB
G
Ranivisio 10 mg/ml
k.A.
Solution injectable en seringue prête à l'emploi: Ranibizumabum 10 mg/ml
Bioeq AG
FB
G
GEM Hustenstiller mit
Noscapinum 10 mg
24
k.A.
Pastilles: Noscapinum 10 mg
Tentan AG
FB
G
Aqumeldi 0.25 mg
50
k.A.
Comprimés orodispersibles: Enalaprili Maleas
pharma services
Oehler GmbH
FB
G
Aqumeldi 0.25 mg
100
k.A.
Comprimés orodispersibles: Enalaprili Maleas
pharma services
Oehler GmbH
FB
G
Aqumeldi 0.25 mg
200
k.A.
Comprimés orodispersibles: Enalaprili Maleas
pharma services
Oehler GmbH
FB
G
Aqumeldi 1 mg
50
k.A.
Comprimés orodispersibles: Enalaprili Maleas 1 mg
pharma services
Oehler GmbH
FB
G
Aqumeldi 1 mg
100
k.A.
Comprimés orodispersibles: Enalaprili Maleas 1 mg
pharma services
Oehler GmbH
FB
G
Aqumeldi 1 mg
200
k.A.
Comprimés orodispersibles: Enalaprili Maleas 1 mg
pharma services
Oehler GmbH
FB
G
Imaavy 1200 mg/6.5 ml
(185 mg/ml)
k.A.
Concentré pour perfusion: Nipocalimabum 1200mg / 6.5ml
Janssen-Cilag AG
FB
G
Imaavy 300 mg/1.62 ml
(185 mg/ml)
k.A.
Concentré pour perfusion: Nipocalimabum 300mg / 1.62ml
Janssen-Cilag AG
FB
G
Meropenem OrPha 500 mg
k.A.
Substance sèche: Meropenemum 500 mg
OrPha Swiss GmbH
FB
G
Meropenem OrPha 500 mg
10
k.A.
Substance sèche: Meropenemum 500 mg
OrPha Swiss GmbH
FB
G
Meropenem OrPha 1 g
k.A.
Substance sèche: Meropenemum 1 g
OrPha Swiss GmbH
FB
G
Meropenem OrPha 1 g
10
k.A.
Substance sèche: Meropenemum 1 g
OrPha Swiss GmbH
FB
G
CM
Alfuzosin Spirig HC
retard 10 mg
10
k.A.
Comprimés retards: Alfuzosini Hydrochloridum 10 mg
Spirig HealthCare AG
FB
G
CM
Alfuzosin Spirig HC
retard 10 mg
30
k.A.
Comprimés retards: Alfuzosini Hydrochloridum 10 mg
Spirig HealthCare AG
FB
G
CM
Alfuzosin Spirig HC
retard 10 mg
90
k.A.
Comprimés retards: Alfuzosini Hydrochloridum 10 mg
Spirig HealthCare AG
FB
G
Apixaban Viatris 2.5 mg
20
k.A.
Comprimés filmés: Apixabanum 2.5 mg
Viatris Pharma GmbH
FB
G
Apixaban Viatris 2.5 mg
56
k.A.
Comprimés filmés: Apixabanum 2.5 mg
Viatris Pharma GmbH
FB
G
Apixaban Viatris 2.5 mg
60
k.A.
Comprimés filmés: Apixabanum 2.5 mg
Viatris Pharma GmbH
FB
G
Apixaban Viatris 2.5 mg
100
k.A.
Comprimés filmés: Apixabanum 2.5 mg
Viatris Pharma GmbH
FB
G
Apixaban Viatris 2.5 mg
168
k.A.
Comprimés filmés: Apixabanum 2.5 mg
Viatris Pharma GmbH
FB
G
Apixaban Viatris 5 mg
56
k.A.
Comprimés filmés: Apixabanum 5 mg
Viatris Pharma GmbH
FB
G
Apixaban Viatris 5 mg
60
k.A.
Comprimés filmés: Apixabanum 5 mg
Viatris Pharma GmbH
FB
G
Apixaban Viatris 5 mg
100
k.A.
Comprimés filmés: Apixabanum 5 mg
Viatris Pharma GmbH
FB
G
Apixaban Viatris 5 mg
168
k.A.
Comprimés filmés: Apixabanum 5 mg
Viatris Pharma GmbH
FB
G
Edoxaban Sandoz 15 mg
10
k.A.
Comprimés filmés: Edoxabanum 15 mg
Sandoz
Pharmaceuticals AG
FB
G
Edoxaban Sandoz 30 mg
28
k.A.
Comprimés filmés: Edoxabanum 30 mg
Sandoz
Pharmaceuticals AG
FB
G
Edoxaban Sandoz 30 mg
98
k.A.
Comprimés filmés: Edoxabanum 30 mg
Sandoz
Pharmaceuticals AG
FB
G
Edoxaban Sandoz 60 mg
28
k.A.
Comprimés filmés: Edoxabanum 60 mg
Sandoz
Pharmaceuticals AG
FB
G
Edoxaban Sandoz 60 mg
98
k.A.
Comprimés filmés: Edoxabanum 60 mg
Sandoz
Pharmaceuticals AG
FB
G
Eltrombopag Devatis 25 mg
14
k.A.
Comprimés filmés: Eltrombopagum 25 mg
Devatis AG
FB
G
Eltrombopag Devatis 25 mg
28
k.A.
Comprimés filmés: Eltrombopagum 25 mg
Devatis AG
FB
G
Eltrombopag Devatis 50 mg
14
k.A.
Comprimés filmés: Eltrombopagum 50 mg
Devatis AG
FB
G
Eltrombopag Devatis 50 mg
28
k.A.
Comprimés filmés: Eltrombopagum 50 mg
Devatis AG
FB
G
Eltrombopag Devatis 75 mg
28
k.A.
Comprimés filmés: Eltrombopagum 75 mg
Devatis AG
FB
G
Macitentan NOBEL 10 mg
30
k.A.
Comprimés filmés: Macitentanum 10 mg
NOBEL Pharma Schweiz AG
FB
G
Macitentan Zentiva 10 mg
30
k.A.
Comprimés filmés: Macitentanum 10 mg
Helvepharm AG
FB
G
CM
Naproxen Esomeprazol
Grünenthal 500 mg/20 mg
30
k.A.
Comprimés filmés: 2 Active Agents
Grünenthal Pharma AG
FB
G
CM
Naproxen Esomeprazol
Grünenthal 500 mg/20 mg
60
k.A.
Comprimés filmés: 2 Active Agents
Grünenthal Pharma AG
FB
G
Sacubitril-Valsartan-
Mepha 24 mg/26 mg
28
k.A.
Comprimés filmés: 2 Active Agents
Mepha Pharma AG
FB
G
Sacubitril-Valsartan-
Mepha 24 mg/26 mg
56
k.A.
Comprimés filmés: 2 Active Agents
Mepha Pharma AG
FB
G
Sacubitril-Valsartan-
Mepha 49 mg/51 mg
56
k.A.
Comprimés filmés: 2 Active Agents
Mepha Pharma AG
FB
G
Sacubitril-Valsartan-
Mepha 49 mg/51 mg
168
k.A.
Comprimés filmés: 2 Active Agents
Mepha Pharma AG
FB
G
Sacubitril-Valsartan-
Mepha 97 mg/103 mg
56
k.A.
Comprimés filmés: 2 Active Agents
Mepha Pharma AG
FB
G
Sacubitril-Valsartan-
Mepha 97 mg/103 mg
168
k.A.
Comprimés filmés: 2 Active Agents
Mepha Pharma AG
FB
G
Teriflunomid Accord 14 mg
28
k.A.
Comprimés filmés: Teriflunomidum 14 mg
Accord Healthcare AG
FB
G
Teriflunomid Accord 14 mg
84
k.A.
Comprimés filmés: Teriflunomidum 14 mg
Accord Healthcare AG
FB
G
Ticagrelor Devatis 60 mg
56
k.A.
Comprimés filmés: Ticagrelorum 60 mg
Devatis AG
FB
G
Ticagrelor Devatis 60 mg
168
k.A.
Comprimés filmés: Ticagrelorum 60 mg
Devatis AG
FB
G
Ticagrelor Devatis 90 mg
56
k.A.
Comprimés filmés: Ticagrelorum 90 mg
Devatis AG
FB
G
Ticagrelor Devatis 90 mg
100
k.A.
Comprimés filmés: Ticagrelorum 90 mg
Devatis AG
FB
G
Ticagrelor Devatis 90 mg
168
k.A.
Comprimés filmés: Ticagrelorum 90 mg
Devatis AG
FB
G
IP
Bylvay 400 μg
30
k.A.
Capsules: 2 Active Agents
Ipsen Pharma Schweiz
GmbH
B
FB
G
IP
Bylvay 600 μg
30
k.A.
Capsules: 2 Active Agents
Ipsen Pharma Schweiz
GmbH
B
FB
G
IP
Bylvay 1200 μg
30
k.A.
Capsules: 2 Active Agents
Ipsen Pharma Schweiz
GmbH
B
FB
G
Fluco axapharm 50 mg
7
k.A.
Capsules: Fluconazolum 50 mg
axapharm ag
FB
G
Fluco axapharm 50 mg
28
k.A.
Capsules: Fluconazolum 50 mg
axapharm ag
FB
G
Fluco axapharm 150 mg
k.A.
Capsules: Fluconazolum 150 mg
axapharm ag
FB
G
Fluco axapharm 150 mg
4
k.A.
Capsules: Fluconazolum 150 mg
axapharm ag
FB
G
Fluco axapharm 200 mg
2
k.A.
Capsules: Fluconazolum 200 mg
axapharm ag
FB
G
Fluco axapharm 200 mg
7
k.A.
Capsules: Fluconazolum 200 mg
axapharm ag
FB
G
Lorazepam Leman 1 mg
14
k.A.
Comprimés: Lorazepamum 1 mg
Leman SKL SA
FB
G
Lorazepam Leman 1 mg
20
k.A.
Comprimés: Lorazepamum 1 mg
Leman SKL SA
FB
G
Lorazepam Leman 1 mg
28
k.A.
Comprimés: Lorazepamum 1 mg
Leman SKL SA
FB
G
Lorazepam Leman 1 mg
30
k.A.
Comprimés: Lorazepamum 1 mg
Leman SKL SA
FB
G
Lorazepam Leman 1 mg
50
k.A.
Comprimés: Lorazepamum 1 mg
Leman SKL SA
FB
G
Lorazepam Leman 1 mg
60
k.A.
Comprimés: Lorazepamum 1 mg
Leman SKL SA
FB
G
Lorazepam Leman 1 mg
90
k.A.
Comprimés: Lorazepamum 1 mg
Leman SKL SA
FB
G
Lorazepam Leman 2.5 mg
14
k.A.
Comprimés: Lorazepamum 2.5 mg
Leman SKL SA
FB
G
Lorazepam Leman 2.5 mg
20
k.A.
Comprimés: Lorazepamum 2.5 mg
Leman SKL SA
FB
G
Lorazepam Leman 2.5 mg
28
k.A.
Comprimés: Lorazepamum 2.5 mg
Leman SKL SA
FB
G
Lorazepam Leman 2.5 mg
30
k.A.
Comprimés: Lorazepamum 2.5 mg
Leman SKL SA
FB
G
Lorazepam Leman 2.5 mg
50
k.A.
Comprimés: Lorazepamum 2.5 mg
Leman SKL SA
FB
G
Lorazepam Leman 2.5 mg
60
k.A.
Comprimés: Lorazepamum 2.5 mg
Leman SKL SA
FB
G
Lorazepam Leman 2.5 mg
90
k.A.
Comprimés: Lorazepamum 2.5 mg
Leman SKL SA
FB
G
Nife-Par Leman 5 mg/ml
30 ml
k.A.
Solution (orale): Nifedipinum 5 mg
Leman SKL SA
FB
G
CM
Gomintia
k.A.
Injektionslösung im Fertigpen: Golimumabum 100 mg/ml
Janssen-Cilag AG
FB
G
Ilaris 150 mg/ml
k.A.
Injektionslösung in einem Fertigpen: Canakinumabum 150 mg/ml
Novartis Pharma
Schweiz AG
FB
G
Hibiwash 40 mg/ml
125 ml
k.A.
Lösung zur Anwendung auf der Haut: Chlorhexidini Digluconas 40 mg
MÖLNLYCKE HEALTH CARE AG
FB
G
Hibiwash 40 mg/ml
250 ml
k.A.
Lösung zur Anwendung auf der Haut: Chlorhexidini Digluconas 40 mg
MÖLNLYCKE HEALTH CARE AG
FB
G
Hibiwash 40 mg/ml
500 ml
k.A.
Lösung zur Anwendung auf der Haut: Chlorhexidini Digluconas 40 mg
MÖLNLYCKE HEALTH CARE AG
FB
G
Hibiwash 40 mg/ml
5 l
k.A.
Lösung zur Anwendung auf der Haut: Chlorhexidini Digluconas 40 mg
MÖLNLYCKE HEALTH CARE AG
FB
G
CM
Amlodipine Valsartan
Biovis 5 mg/160 mg
28
k.A.
compresse rivestite con film: 2 Active Agents
Biovis Life Sciences SA
FB
G
CM
Amlodipine Valsartan
Biovis 10 mg/160 mg
28
k.A.
compresse rivestite con film: 2 Active Agents
Biovis Life Sciences SA
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2026
©ywesee GmbH
Settings
|
Help
|
Login
|
Contact
|
Home